Skip to Main Content

Paper Details

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications.
eBioMedicine
9
2022
AAT, ARDS, Diabetes, Digestive and Kidney Diseases, IL-6, IL-6 receptor, Interleukin-6, NE, NET, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 ARDS, SARS-CoV-2 infection, TA, Tocilizumab, acute respiratory distress syndrome, alpha-1 antitrypsin, neutrophil elastase, neutrophils, non-SARS-CoV-2 ARDS, nsARDS, patients, people, plasma, secretory leukoprotease inhibitor, tocilizumab
Author NameAffiliation
Leigh ThorneUniversity of North Carolina at Chapel Hill
Alain C Borczuk
Kenichi OkudaMarsico Lung Institute/Cystic Fibrosis Research Center, University of North Carolina at Chapel Hill
Matthew C WolfgangMarsico Lung Institute/Cystic Fibrosis Research Center, University of North Carolina at Chapel Hill, University of North Carolina School of Medicine
Richard C BoucherMarsico Lung Institute/Cystic Fibrosis Research Center, University of North Carolina at Chapel Hill
Noel G McElvaneyRCSI Education and Research Centre, Beaumont Hospital, Ireland Royal College of Surgeons in Ireland
  • 1 - 6

Datasets

Release 1.2